Australian economic evaluation and government decisions on pharmaceuticals, compared to assessment of other health technologies
- 1 August 1997
- journal article
- Published by Elsevier in Social Science & Medicine
- Vol. 45 (4) , 563-581
- https://doi.org/10.1016/s0277-9536(96)00397-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The assessment of diagnostic imaging technologies: a policy perspectiveHealth Policy, 1996
- The evolution of heart, lung and liver transplantation services in AustraliaHealth Policy, 1995
- Health care reforms: the unfinished agendaHealth Policy, 1995
- Editorial: The price of urineAustralian Prescriber, 1995
- A cost utility analysis of treatment options for gallstone disease: Methodological issues and resultsHealth Economics, 1994
- Economic Appraisal in the Regulation of Pharmaceuticals in Australia: Its Rationale and Potential ImpactAustralian Economic Review, 1994
- The influence of technology assessments by advisory bodies on health policy and practiceHealth Policy, 1993
- Cost‐effectiveness of mammographic screening in AustraliaAustralian Journal of Public Health, 1993
- The Influence of Health Technology Assessment on the Diffusion of MRI in AustraliaInternational Journal of Technology Assessment in Health Care, 1993
- Economic Analysis and End-Stage Renal Disease – An Australian Study.Economic Analysis and Policy, 1978